Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: the REVELUTION-2 Trial
Latest Information Update: 25 Oct 2024
At a glance
- Drugs Abiraterone acetate (Primary) ; Bicalutamide (Primary) ; Leuprorelin (Primary) ; Leuprorelin (Primary) ; Prednisone (Primary) ; Relugolix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms REVELUTION-2
- 25 Oct 2024 New trial record